TARPLIN, DOWNS & YOUNG, LLC

Lobbying for AMGEN INC

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $60,000.00 income · posted Jul 16, 2026

Lobbying activity 3

Health Issues

Lobbying related to pharmaceutical policy and health care access

Medicare/Medicaid

Lobbying related to pharmaceutical policy and Medicare policy

Budget/Appropriations

federal budget issues

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.